This clinical study evaluates the efficacy of the autologous blood-derived product called platelet- and extracellular vesicle-rich plasma (PVRP) for the treatment of chronically inflamed post-surgical temporal bone cavities. Half of the participants will be treated with platelet- and extracellular vesicle-rich plasma and another half with standard nonsurgical measures.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Inflammation Surface Area.
Timeframe: Baseline, 1 month, 2 months and 3 months after baseline
Change in Chronic Otitis Media Questionnaire 12 Score
Timeframe: Baseline, 1 month, 2 months and 3 months